El cerebro en la sepsis

Referencias

1 Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis 2005; 41 (suppl 7): S490–97.
2 Yealy DM, Kellum JA, Huang DT, et al, for the ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683–93.
3 Vincent JL, Rello J, Marshall J, et al, for the EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323–29.
4 Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010; 304: 1787–94.
5 De Jonghe B, Sharshar T, Lefaucheur JP, et al, for the Groupe de Refl exion et d’Etude des Neuromyopathies en Reanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859–67.
6 Sharshar T, Bastuji-Garin S, Stevens RD, et al, for the Groupe de Refl exion et d’Etude des Neuromyopathies En Reanimation. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 2009; 37: 3047–53.
7 Pandharipande PP, Girard TD, Jackson JC, et al, for the BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med 2013; 369: 1306–16.
8 Sharshar T, Gray F, Lorin de la Grandmaison G, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003;  362: 1799–805.
9 Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G. The neuropathology of septic shock. Brain Pathol 2004; 14: 21–33.
10 Suchyta MR, Jephson A, Hopkins RO. Neurologic changes during critical illness: brain imaging fi ndings and neurobehavioral outcomes. Brain Imaging Behav 2010; 4: 22–34.
11 Polito A, Eischwald F, Maho AL, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care 2013; 17: R204.
12 Annane D, Vignon P, Renault A, et al, for the CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007;370: 676–84.
13 Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fi brillation in patients hospitalized with severe sepsis. JAMA 2011; 306: 2248–54.
14 Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long term outcomes following development of new-onset atrial fi brillation during sepsis. Chest 2014; published online April 10. http://dx.doi.org/10.1378/chest.14-0003.
15 Annane D, Sebille V, Duboc D, et al. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 2008; 178: 20–25.
16 Taccone FS, Su F, De Deyne C, et al. Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis. Crit Care Med 2014; 42: e114–22.
17 de Bruijn MA, Synhaeve NE, van Rijsbergen MW, de Leeuw FE, Jansen BP, de Kort PL. Long-term cognitive outcome of ischaemic stroke in young adults. Cerebrovasc Dis 2014; 37: 376–81.
18 Barber PA, Hach S, Tippett LJ, Ross L, Merry AF, Milsom P. Cerebral ischemic lesions on diff usion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke 2008; 39: 1427–33.
19 Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther 2014; 6: 33.
20 Sonneville R, Verdonk F, Rauturier C, et al. Understanding brain dysfunction in sepsis. Ann Intensive Care 2013; 3: 15.
21 Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Defi nitions, etiologies, and mortalities. JAMA 1996; 275: 470–73.
22 Mikkelsen ME, Christie JD, Lanken PN, et al. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012; 185: 1307–15.
23 De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro)toxins. Semin Dial 2009; 22: 340–45.
24 Deshmukh DR, Ghole VS, Marescau B, De Deyn PP. Eff ect of endotoxemia on plasma and tissue levels of nitric oxide metabolites and guanidino compounds. Arch Physiol Biochem 1997;105: 32–37.
25 Bozza FA, Garteiser P, Oliveira MF, et al. Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab 2010; 30: 440–48.
26 Marzocco S, Popolo A, Bianco G, Pinto A, Autore G. Pro-apoptotic eff ect of methylguanidine on hydrogen peroxide-treated rat glioma cell line. Neurochem Int 2010; 57: 518–24.
27 Guillemin GJ, Wang L, Brew BJ. Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinfl ammation 2005; 2: 16.
28 Polito A, Brouland JP, Porcher R, et al. Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care 2011; 15: R131.
29 Kamada H, Yu F, Nito C, Chan PH. Infl uence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood–brain barrier dysfunction. Stroke 2007; 38: 1044–49.
30 Hopkins RO, Suchyta MR, Snow GL, Jephson A, Weaver LK, Orme JF. Blood glucose dysregulation and cognitive outcome in ARDS survivors. Brain Inj 2010; 24: 1478–84.
31 Duning T, van den Heuvel I, Dickmann A, et al. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 2010; 33: 639–44.
32 Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63–78.
33 Kenney MJ, Ganta CK. Autonomic nervous system and immune system interactions. Compr Physiol 2014; 4: 1177–200.
34 Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic infl ammatory response to endotoxin. Nature 2000; 405: 458–62.
35 Sun D, Lytle C, O’Donnell ME. IL-6 secreted by astroglial cells regulates Na-K-Cl cotransport in brain microvessel endothelial cells. Am J Physiol 1997; 272: C1829–35.
36 McLennan IS, Weible MW 2nd, Hendry IA, Koishi K. Transport of transforming growth factor-beta 2 across the blood–brain barrier. Neuropharmacology 2005; 48: 274–82.
37 Erickson MA, Banks WA. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantifi cation with path analysis. Brain Behav Immun 2011; 25: 1637–48.
38 Deng X, Wang X, Andersson R. Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol (1985) 1995; 78: 2052–61.
39 Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) 1999;96: 461–66.
40 Moss RF, Parmar NK, Tighe D, Davies DC. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit Care Med 2004; 32: 1916–21.
41 Stubbs DJ, Yamamoto AK, Menon DK. Imaging in sepsis-associated encephalopathy—insights and opportunities. Nat Rev Neurol 2013; 9: 551–61.
42 Sharshar T, Carlier R, Bernard F, et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med 2007; 33: 798–806.
43 Skowrońska M, Albrecht J. Alterations of blood brain barrier function in hyperamonemia: an overview. Neurotox Res 2012; 21: 236–44.
44 Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the infl amed human central nervous system. Am J Pathol 1997; 150: 31–41.
45 Vandenbroucke RE, Dejonckheere E, Van Lint P, et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood–CSF barrier contributes to lethality during systemic infl ammatory diseases. J Neurosci 2012; 32: 9805–16.
46 Dal-Pizzol F, Rojas HA, dos Santos EM, et al. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood–brain barrier dysfunction in an animal model of severe sepsis. Mol Neurobiol 2013; 48: 62–70.
47 Nadeau S, Rivest S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J 2001; 15: 1410–12.
48 Weberpals M, Hermes M, Hermann S, et al. NOS2 gene defi ciency protects from sepsis-induced long-term cognitive defi cits. J Neurosci 2009; 29: 14177–84.
49 Yende S, D’Angelo G, Kellum JA, et al, for the GenIMS Investigators. Infl ammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177: 1242–47.
50 Ferrari CC, Pott Godoy MC, Tarelli R, Chertoff M, Depino AM, Pitossi FJ. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol Dis 2006; 24: 183–93.
51 Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y. A critical role of astrocyte-mediated nuclear factor-κB-dependent infl ammation in Huntington’s disease. Hum Mol Genet 2013; 22: 1826–42.
52 Singh-Manoux A, Dugravot A, Brunner E, et al. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 2014; 83: 486–93.
53 Hernandes MS, D’Avila JC, Trevelin SC, et al. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinfl ammation 2014; 11: 36.
54 Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol 2011; 70: 583–90.
55 Kadoi Y, Saito S, Kunimoto F, Imai T, Fujita T. Impairment of the brain beta-adrenergic system during experimental endotoxemia. J Surg Res 1996; 61: 496–502.
56 Kadoi Y, Saito S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med 1996; 24: 298–305.
57 Semmler A, Frisch C, Debeir T, et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol 2007; 204: 733–40.
58 van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010; 375: 773–75.
59 Pandharipande PP, Pun BT, Herr DL, et al. Eff ect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644–53.
60 Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007; 21: 153–60.
61 Sharshar T, Porcher R, Siami S, et al, for the Paris-Ouest Study Group on Neurological Eff ect of Sedation (POSGNES). Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med 2011; 39: 1960–67.
62 Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992; 9: 145–52.
63 Synek VM. Prognostically important EEG coma patterns in diff use anoxic and traumatic encephalopathies in adults. J Clin Neurophysiol 1988; 5: 161–74.
64 Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Jr. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171: 340–47.
65 Needham DM, Dinglas VD, Morris PE, et al, for the NIH NHLBI ARDS Network. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med 2013; 188: 567–76.
66 Jackson JC, Girard TD, Gordon SM, et al. Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med 2010; 182: 183–91.
67 Girard TD, Kress JP, Fuchs BD, et al. Effi cacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126–34.
68 Shah FA, Pike F, Alvarez K, et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med 2013; 188: 586–92.
69 Semmler A, Widmann CN, Okulla T, et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry 2013; 84: 62–69.
70 Gunther ML, Morandi A, Krauskopf E, et al, for the VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae. The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study. Crit Care Med 2012; 40: 2022–32.
71 Teng EL, Chui HC. The Modifi ed Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314–18.
72 Welsh KA, Breitner JC, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993; 6: 103–10.
73 Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr 2004; 16: 275–93.
74 Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20: 310–19.
75 Reitan RM, Wolfson D. The Halstead Reitan neuropsychological test battery. Tucson: Neuropsychology Press, 1985.
76 Herridge MS, Tansey CM, Matte A, et al, for the Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364: 1293–304.
77 Dellinger RP, Levy MM, Rhodes A, et al, for the Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165–228.
78 Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012; 12: 919–24.
79 Mesotten D, Gielen M, Sterken C, et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA 2012; 308: 1641–50.
80 Schricker T, Sato H, Beaudry T, Codere T, Hatzakorzian R, Pruessner JC. Intraoperative maintenance of normoglycemia with insulin and glucose preserves verbal learning after cardiac surgery. PLoS One 2014; 9: e99661.
81 Zhou W, Marinescu M, Veltkamp R. Only very early oxygen therapy attenuates posthemorrhagic edema formation and blood–brain barrier disruption in murine intracerebral hemorrhage. Neurocrit Care 2014; published online Jul 15. http://dx.doi. org/10.1007/s12028-014-0013-9.
82 Ertmer C, Van Aken H. Fluid therapy in patients with brain injury: what does physiology tell us? Crit Care 2014; 18: 119.
83 Annabi B, Lachambre MP, Plouff e K, Moumdjian R, Beliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009; 60: 438–45.
84 Hempel C, Hoyer N, Kildemoes A, Jendresen CB, Kurtzhals JA. Systemic and cerebral vascular endothelial growth factor levels increase in murine cerebral malaria along with increased calpain and caspase activity and can be reduced by erythropoietin treatment. Front Immunol 2014; 5: 291.
85 Widiapradja A, Santro T, Basta M, Sobey CG, Manzanero S, Arumugam TV. Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke. Exp Transl Stroke Med 2014; 6: 7.
86 Lu X, Chen-Roetling J, Regan RF. Systemic hemin therapy attenuates blood–brain barrier disruption after intracerebral hemorrhage. Neurobiol Dis 2014; 70: 245–51.
87 Forster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. Diff erential eff ects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the
human blood–brain barrier. J Physiol 2008;  586: 1937–49.
88 Kashiwamura Y, Sano Y, Abe M, et al. Hydrocortisone enhances the function of the blood–nerve barrier through the up-regulation of claudin-5. Neurochem Res 2011; 36: 849–55.
89 Terrando N, Rei Fidalgo A, Vizcaychipi M, et al. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care 2010; 14: R88.
90 Leinhase I, Rozanski M, Harhausen D, et al. Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J Neuroinfl ammation 2007; 4: 13.
91 Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinfl ammation 2008; 5: 5.
92 Adembri C, Selmi V, Vitali L, et al. Minocycline but not tigecycline is neuroprotective and reduces the neuroinfl ammatory response induced by the superimposition of sepsis upon traumatic brain injury. Crit Care Med 2014; 42: e570–82.
93 Michels M, Vieira AS, Vuolo F, et al. The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain Behav Immun 2014; published online July 11.http://dx.doi.org/10.1016/j.bbi.2014.07.002.
94 Fang J, Lian Y, Xie K, Cai S, Wen P. Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. Neurol Sci 2014; 35: 283–88.
95 Wu J, Dong L, Zhang M, et al. Class I histone deacetylase inhibitor valproic acid reverses cognitive defi cits in a mouse model of septic encephalopathy. Neurochem Res 2013; 38: 2440–49.
96 Comim CM, Pereira JG, Steckert A, et al. Rivastigmine reverses habituation memory impairment observed in sepsis survivor rats. Shock 2009; 32: 270–71.
97 van Eijk MM, Roes KC, Honing ML, et al. Eff ect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010;376: 1829–37.
98 Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373: 1874–82.
99 Jackson J, Ely EW, Morey MC, et al. Cognitive and physical rehabilitation of ICU survivors: results of the RETURN randomized, controlled pilot investigation. Crit Care Med 2012;40: 1088–97.
100 Brummel NE, Jackson JC, Girard TD, et al. A combined early cognitive and physical rehabilitation program for people who are critically ill: the activity and cognitive therapy in the intensive care unit (ACT-ICU) trial. Phys Ther 2012; 92: 1580–92.